Table 1.
Demographic and clinical characteristics of the study population
| Age in years (mean, SD) | 3.92 ± 2.32 |
| Sex, n (%) | |
| Male | 223 (52.7) |
| Female | 200 (47.3) |
| Weight in kg (mean, SD) | 15.47 ± 5.21 |
| Blood group, n (%) | |
| O+ | 166 (39.4) |
| A+ | 96 (22.8) |
| B+ | 128 (30.4) |
| AB | 27 (6.4) |
| Non O (A+ B+ AB + others) | 255 (60.6) |
| Sickle cell genotype, n (%) | |
| Wild type (Hb AA) | 303 (73.2) |
| Heterozygous (Hb AS) | 110 (26.6) |
| Homozygous (Hb SS) | 1 (0.2) |
| Mean haemoglobin, SD (g/dL) | 11.97 ± 1.46 |
| Malaria history, n (%) | |
| Yes | 400 (94.6) |
| No | 15 (3.5) |
| Not sure | 8 (1.9) |
| Reported ITN use, n (%) | |
| Yes | 373 (88.2) |
| No | 50 (11.8) |
| Reported previous anti-malarial drug use, n (%) | |
| Yes | 403 (95.3) |
| No | 14 (3.3) |
| Not sure | 6 (1.4) |